Cargando…
Methylphenidate Multiphasic Release Tablet: Bioequivalence Assessment between Two Formulations Administered under Fasting and Fed Conditions
Methylphenidate hydrochloride is used to treat children, adolescents, and adults with attention deficit/hyperactivity disorder (ADHD). Multiphasic release formulation has been used to control drug levels, mainly during children’s school period. This study aimed to evaluate the bioequivalence between...
Autores principales: | Davanço, Marcelo Gomes, Meulman, Jessica, da Silva, Thalita Martins, Costa, Fernando, Bellorio, Karini Bruno, Mundim, Iram Moreira, Sampaio, Ana Carolina Costa, Teixeira, Leonardo de Souza, Vespasiano, Celso Francisco Pimentel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10304685/ https://www.ncbi.nlm.nih.gov/pubmed/37376185 http://dx.doi.org/10.3390/pharmaceutics15061737 |
Ejemplares similares
-
Etoricoxib Coated Tablets: Bioequivalence Assessment between Two Formulations Administered under Fasting Conditions
por: Meulman, Jessica, et al.
Publicado: (2023) -
Bioequivalence of Sandoz methylphenidate osmotic-controlled release tablet with Concerta® (Janssen-Cilag)
por: Schapperer, Elisabeth, et al.
Publicado: (2015) -
Bioequivalence Evaluation of Two Formulations of Tenofovir Alafenamide Tablets in Healthy Subjects Under Fasting and Fed Conditions
por: Li, Qiuying, et al.
Publicado: (2021) -
Bioequivalence of two tablet formulations of cefpodoxime proxetil in beagle dogs
por: Gao, Yan-Yan, et al.
Publicado: (2022) -
Bioequivalence Study of Amitriptyline Hydrochloride Tablets in Healthy Chinese Volunteers Under Fasting and Fed Conditions
por: Zhai, You, et al.
Publicado: (2020)